Goldfarb Branham Law Firm LLP Investigating Shareholder Claims in Cephalon, Inc. Buyout
May 03 2011 - 9:46AM
Business Wire
Goldfarb Branham LLP is investigating the takeover of Cephalon,
Inc. (Nasdaq: CEPH) by Teva Pharmaceutical Industries, Ltd. to
ensure that shareholders’ rights are preserved in the buyout for
$81.50 per share. Concerned Cephalon shareholders are encouraged to
contact attorney Hamilton Lindley at 877-583-2855 or
hlindley@goldfarbbranham.com about their rights and remedies.
“This buyout is a 6% premium over the previous day’s closing
price,” said securities lawyer Hamilton Lindley. “Analysts have
placed the price target at between $92 and $119 per share. Our
firm’s potential stockholder lawsuit seeks to ensure that
investors’ receive the fair price and information that they are
entitled to as Cephalon stockholders.”
Goldfarb Branham LLP lawyers have significant experience
representing shareholders and whistleblowers in securities lawsuits
nationwide. Cephalon investors – or anyone with knowledge about
this issue – should contact lawyer Hamilton Lindley at
hlindley@goldfarbbranham.com or 877-583-2855.
Cephalon (NASDAQ:CEPH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Cephalon (NASDAQ:CEPH)
Historical Stock Chart
From Jul 2023 to Jul 2024